Pygo2 activates BRPF1 via Pygo2–H3K4me2/3 interaction to maintain malignant progression in colon cancer
-
Published:2023-10
Issue:1
Volume:431
Page:113696
-
ISSN:0014-4827
-
Container-title:Experimental Cell Research
-
language:en
-
Short-container-title:Experimental Cell Research
Author:
Ling Jie,
Tang Zhijie,
Yang Wei,
Li Ye,
Dong XiaoqiangORCID
Reference35 articles.
1. Cancer statistics, 2022;Siegel;CA A Cancer J. Clin.,2022
2. Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment;Jahanafrooz;J. Cell. Physiol.,2020
3. Pathophysiology, clinical presentation, and management of colon cancer;Cappell;Gastroenterol. Clin. N. Am.,2008
4. Terminology, molecular features, epidemiology, and management of serrated colorectal neoplasia;Crockett;Gastroenterology,2019
5. Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients;Dienstmann;J. Clin. Oncol.,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献